Related Experiment Video
Updated: Jun 12, 2026

09:34
Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
[Association study between exon 4 NFKBIL1 polymorphism and multiple sclerosis]
Michał Krzysztof Owecki1, Piotr Kowal, Marta Kaczmarek-Ryśs
1Uniwersytet Medyczny w Poznaniu, Katedra i Klinika Neurologii. michal.owecki@wp.pl
Summary
This study found no link between the NFKBIL1 exon 4 polymorphism and multiple sclerosis (MS) predisposition in the Polish population. However, this genetic variation may influence MS disease course and potentially protect against optic neuritis.
Area of Science:
- Genetics
- Immunology
- Neurology
Background:
- Multiple sclerosis (MS) is an autoimmune inflammatory disease with suspected genetic and environmental factors.
- The NFKBIL1 gene, located at locus 6p21.31, is a candidate gene for MS predisposition.
- A specific polymorphism in NFKBIL1 exon 4 involves a thymine-cytosine substitution, leading to a cysteine-arginine change in the encoded protein.
Purpose of the Study:
- To investigate the contribution of the NFKBIL1 exon 4 polymorphism to genetic predisposition for MS.
- To examine the relationship between this polymorphism and the clinical progression of MS.
Main Methods:
- The study included 107 unrelated MS patients and 110 healthy controls from the Polish population.
- Single-strand conformation polymorphism (SSCP) technique was used to analyze the NFKBIL1 exon 4 polymorphism.
- Statistical analysis was performed to assess associations with MS predisposition and clinical parameters.
Main Results:
- The NFKBIL1 exon 4 polymorphism was detected in 9.35% of MS patients and 8.18% of controls, a difference that was not statistically significant (p = 0.8136).
- No significant associations were found between the polymorphism and MS course, onset symptoms, sex, or optic neuritis (ON).
- Despite non-significance, observed differences in male patients and ON-negative individuals suggest potential roles that warrant further investigation with larger cohorts.
Conclusions:
- The NFKBIL1 exon 4 polymorphism is not associated with MS predisposition in the studied Polish population.
- The polymorphism might have a limited impact on the course of MS.
- A potential protective effect of this polymorphism on optic neuritis in MS patients was suggested but requires further validation.
Related Concept Videos
NF-κB-dependent Signaling Pathway
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...